Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation

被引:402
作者
Di Agostino, Silvia
Strano, Sabrina
Emiliozzi, Velia
Zerbini, Valentina
Mottolese, Farcella
Sacchi, Ada
Blandino, Giovanni
Piaggio, Giulia
机构
[1] Ist Regina Elena, Dept Expt Oncol, I-00158 Rome, Italy
[2] Ist Regina Elena, ROC, I-00158 Rome, Italy
[3] Ist Regina Elena, Dept Anat Pathol, I-00128 Rome, Italy
关键词
D O I
10.1016/j.ccr.2006.08.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
This article investigates the mechanistic aspects of mutant p53 "gain of function" in response to DNA damage. We show that mutant forms of p53 protein interact with NF-Y. The expression of cyclin A, cyclin B1, cdkl, and cdc25C, as well as the cdkl associated kinase activities, is upregulated after DNA damage, provoking a mutant p53/NF-Y-dependent increase in DNA synthesis. Mutant p53 binds NF-Y target promoters and, upon DNA damage, recruits p300, leading to histone acetylation. The recruitment of mutant p53 to the CCAAT sites is severely impaired upon abrogation of NF-YA expression. Enclogenous NF-Y, mutant p53, and p300 proteins form a triple complex upon DNA damage. We demonstrate that aberrant transcriptional regulation underlies the ability of mutant p53 proteins to act as oncogenic factors.
引用
收藏
页码:191 / 202
页数:12
相关论文
共 40 条
[1]
Cell-cycle regulation of the DNA topoisomerase IIα promoter is mediated by proximal CCAAT boxes:: possible involvement of acetylation [J].
Adachi, N ;
Nomoto, M ;
Kohno, K ;
Koyama, H .
GENE, 2000, 245 (01) :49-57
[2]
p53 gene mutation:: software and database [J].
Béroud, C ;
Soussi, T .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :200-204
[3]
Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy [J].
Blandino, G ;
Levine, AJ ;
Oren, M .
ONCOGENE, 1999, 18 (02) :477-485
[4]
The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated [J].
Bolognese, F ;
Wasner, M ;
Lange-zu Dohna, C ;
Gurtner, A ;
Ronchi, A ;
Muller, H ;
Manni, I ;
Mossner, J ;
Piaggio, G ;
Mantovani, R ;
Engeland, K .
ONCOGENE, 1999, 18 (10) :1845-1853
[5]
A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[6]
Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters [J].
Caretti, G ;
Salsi, V ;
Vecchi, C ;
Imbriano, C ;
Mantovani, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (33) :30435-30440
[7]
Di Como CJ, 2002, CLIN CANCER RES, V8, P494
[8]
GAIN OF FUNCTION MUTATIONS IN P53 [J].
DITTMER, D ;
PATI, S ;
ZAMBETTI, G ;
CHU, S ;
TERESKY, AK ;
MOORE, M ;
FINLAY, C ;
LEVINE, AJ .
NATURE GENETICS, 1993, 4 (01) :42-46
[9]
El-Hizawi S, 2002, CANCER RES, V62, P3264
[10]
Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells [J].
Elkon, R ;
Linhart, C ;
Sharan, R ;
Shamir, R ;
Shiloh, Y .
GENOME RESEARCH, 2003, 13 (05) :773-780